ArticleBlood cancer journal2025

Carfilzomib prescribing patterns and outcomes for relapsed or refractory multiple myeloma: a real-world analysis.

Sharlene Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.